Influencing COX-2 activity by COX related pathways in inflammation and cancer

T Yu, X Lao, H Zheng - Mini reviews in medicinal chemistry, 2016 - ingentaconnect.com
Cancer is a major cause of death worldwide despite significant advances in surgery and
biology. Several recent studies have suggested that there is a close connection between …

Biology of Cox-2: an application in cancer therapeutics

Z Khan, N Khan, RP Tiwari, NK Sah… - Current drug …, 2011 - ingentaconnect.com
Cyclooxygenase-2 (Cox-2) is an inducible enzyme involved in the conversion of arachidonic
acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed …

COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers

P Rodrigues, H Bangali, A Hammoud, YF Mustafa… - Medical Oncology, 2024 - Springer
Cyclooxygenase (COX) enzymes are pivotal in inflammation and cancer development. COX-
2, in particular, has been implicated in tumor growth, angiogenesis, and immune evasion …

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

AT Koki, KM Leahy, JL Masferrer - Expert opinion on …, 1999 - Taylor & Francis
Increased prostaglandin (PG) production is associated with many inflammatory
pathophysiological conditions; it is derived from arachidonic acid by either of two enzymes …

COX-2 signaling and cancer: new players in old arena

S Misra, K Sharma - Current drug targets, 2014 - ingentaconnect.com
Cancer is a leading cause of death worldwide. The expression of COX-2 and prostaglandins
has not only been associated with various types of cancer but is also directly proportional to …

Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents

AS Kalgutkar, Z Zhao - Current Drug Targets, 2001 - ingentaconnect.com
The recent marketing of two selective cyclooxygenase-2 (COX-2) inhibitors, celecoxib and
rofecoxib is remarkable considering that COX-2 was only discovered eight years ago as a …

NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase

OR Kolawole, K Kashfi - International journal of molecular sciences, 2022 - mdpi.com
Acute inflammation or resolved inflammation is an adaptive host defense mechanism and is
self-limiting, which returns the body to a state of homeostasis. However, unresolved …

Role of COX-2 selective inhibitors for prevention and treatment of cancer

M Amir, HK Agarwal - Die Pharmazie-An International Journal …, 2005 - ingentaconnect.com
Cyclooxygenase-2 (COX-2) is an enzyme induced by inflammatory and mitogenic stimuli
and results in enhanced synthesis of PGs in inflamed and neoplastic tissues. It is associated …

Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity

A Telliez, C Furman, N Pommery… - Anti-Cancer Agents in …, 2006 - ingentaconnect.com
The biological role of COX-2, the inducible form of cyclooxygenase, is to convert arachidonic
acid into prostaglandins (PGs) and thromboxanes (TXs). Overexpressed in many tumors …

Cyclooxygenase-1 (COX-1) and COX-1 inhibitors in cancer: A review of oncology and medicinal chemistry literature

A Pannunzio, M Coluccia - Pharmaceuticals, 2018 - mdpi.com
Prostaglandins and thromboxane are lipid signaling molecules deriving from arachidonic
acid by the action of the cyclooxygenase isoenzymes COX-1 and COX-2. The role of …